Marimed (MRMD) Interest Expenses (2014 - 2026)

Marimed (MRMD) has reported Interest Expenses for 13 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest Expenses rose 13.9% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $8.0 million, a 11.89% increase from a year earlier, with the FY2025 full-year figure at $7.5 million, up 8.04% from the prior year.
• Interest Expenses was $2.0 million for Q2 2026 at Marimed, up from $2.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $2.6 million in Q2 2023 and troughed at $313000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2025 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 79.3% in 2022 and soared 700.32% in 2023, its largest moves.
• Over 5 years, Interest Expenses stood at $422000.0 in 2022, then soared by 269.19% to $1.6 million in 2023, then advanced by 21.05% to $1.9 million in 2024, then rose by 14.16% to $2.2 million in 2025, then retreated by 6.78% to $2.0 million in 2026.
• The last three Interest Expenses figures came in at $2.0 million (Q2 2026), $2.0 million (Q1 2026), and $2.2 million (Q4 2025), per Business Quant data.